ADMIN CORE: VANDERBILT? INGRAM CANCER CENTER ADMINISTRATION/SENIOR LEADERSHIP PROJECT SUMMARY/ABSTRACT Vanderbilt-Ingram Cancer Center (VICC) Administration assists the Director, Senior Leaders, Program Leaders, Shared Resource Directors/Managers, visiting speakers, external board members, donors and general membership in carrying out VICC's mission through administrative management, centralized services and overall planning and evaluation. As a matrix center, VICC supports key faculty and staff involved with the CCSG and its ancillary activities, including those that occupy VICC space and other research space across the institution, recipients of VICC philanthropic funds, and leaders of multi-investigator/multi-institutional grants or clinical research contractual agreements. Administration staffs all internal and external planning and evaluation efforts, and support to VICC membership, oversight of shared resources, faculty recruitment, administration of pilot projects and internal research awards, oversight of space and facilities, communications such as newsletters, publications, staff to Research Program Leaders and Executive Committee meetings, and oversees Center budgets and finance. Administration's success is demonstrated through the extensive work with Senior Leadership in implementing new research strategies, administrative support for the many multi- investigator and multi-institutional awards received by VICC members during the current funding period, in addition to the new faculty recruits and new initiatives made possible through philanthropy, and new informatics-based administrative tools. VICC has a strong leadership team that encompasses expertise across all facets of the cancer research and clinical enterprises and provides oversight of basic, clinical, translational, prevention, control and population-based research programs. Working collaboratively and effectively, the senior leaders have enhanced organizational capabilities and planning and evaluation activities to meet the needs of a growing cancer center. The executive senior leadership team identifies and recruits new associate directors, new Program Leaders and co-Leaders, and new shared resource leaders. In some cases these recruitments provide career development and mentored leadership opportunities and overall, ensure robust succession planning. During the current period, VICC executive leadership worked with the VUMC senior clinical and research leadership to establish a new Cancer Patient Care Center, a Center for Cancer Targeted Therapies, and the Cancer Health Equity Working Group. Senior Leadership includes the Director; Deputy Director; and the Associate Directors for Clinical Research, Population-Based Research, Basic Research and Shared Resources, Research Education, Global Health and Quantitative Sciences.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-23
Application #
9553499
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
23
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Bloodworth, Melissa H; Rusznak, Mark; Pfister, Connor C et al. (2018) Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology. J Allergy Clin Immunol 142:683-687.e12
Saito-Diaz, Kenyi; Benchabane, Hassina; Tiwari, Ajit et al. (2018) APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev Cell 44:566-581.e8
Cardin, Dana B; Thota, Ramya; Goff, Laura W et al. (2018) A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer. Am J Clin Oncol 41:772-776
Hormuth 2nd, David A; Weis, Jared A; Barnes, Stephanie L et al. (2018) Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer. Int J Radiat Oncol Biol Phys 100:1270-1279
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Vierra, Nicholas C; Dickerson, Matthew T; Jordan, Kelli L et al. (2018) TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion. Mol Metab 9:84-97
Schlegel, Cameron; Weis, Victoria G; Knowles, Byron C et al. (2018) Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease. Dig Dis Sci 63:356-365
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Werfel, Thomas A; Wang, Shan; Jackson, Meredith A et al. (2018) Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival. Cancer Res 78:1845-1858

Showing the most recent 10 out of 2462 publications